EFFECTS OF CHLORMERODRIN, P-CHLOROMERCURIBENZOATE AND DICHLORPHENAMIDE ON RENAL SODIUM REABSORPTION AND OXYGEN CONSUMPTION.
D000818:Animals; D001565:Benzoates; D002257:Carbonic Anhydrase Inhibitors; D002717:Chlormerodrin; D002729:Chloromercuribenzoates; D004005:Dichlorphenamide; D004232:Diuretics; D004285:Dogs; D007668:Kidney; D007677:Kidney Function Tests; D008628:Mercury; D008660:Metabolism; D009941:Organomercury Compounds; D010101:Oxygen Consumption; D010600:Pharmacology; D012106:Research; D012964:Sodium
D001565:Benzoates; D002257:Carbonic Anhydrase Inhibitors; D002729:Chloromercuribenzoates; D004232:Diuretics; D009941:Organomercury Compounds; D002717:Chlormerodrin; D012964:Sodium; D008628:Mercury; D004005:Dichlorphenamide
BENZOATES; CARBONIC ANHYDRASE INHIBITORS; CHLORMERODRIN; CHLOROMERCURIBENZOATES; DICHLORPHENAMIDE; DIURETICS, MERCURIAL; DOGS; EXPERIMENTAL LAB STUDY; KIDNEY; KIDNEY FUNCTION TESTS; MERCURY; METABOLISM; PHARMACOLOGY; SODIUM